You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君正集團(601216.SH):拉薩盛泰擬對大安製藥增資11.22億元 持股將達31.17%
格隆匯 03-17 19:59

格隆匯3月17日丨君正集團(601216.SH)公佈,公司關聯方河北大安製藥有限公司(以下簡稱“大安製藥”)擬以增資擴股方式引進戰略投資者,其中公司全資控股公司拉薩經濟技術開發區盛泰信息科技發展有限公司(以下簡稱“拉薩盛泰”)擬以現金11.22億元對大安製藥進行增資,認購大安製藥新增註冊資本3.57億元。

截至目前,大安製藥註冊資本為6.54億元;此外,大安製藥股東北京通盈投資集團有限公司依據其與大安製藥於2019年8月5日簽署的《河北大安製藥有限公司與北京通盈投資集團有限公司之增資協議》,尚有對大安製藥未履行完畢的出資義務(以下簡稱“前次增資”)。

前次增資及本次增資完成後,大安製藥的註冊資本將增加至11.46億元,拉薩盛泰佔大安製藥本次增資後註冊資本的31.17%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account